# EDGAR Filing Document

**Accession Number:** 0001063537
**File Stem:** 0001437749-23-006892
**Filing Date:** 2023-3
**Character Count:** 26943
**Document Hash:** e9608731f13cc28fb640e205487cac9d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-23-006892.hdr.sgml**: 20230316

**ACCESSION NUMBER**: 0001437749-23-006892

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20230316

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230316

**DATE AS OF CHANGE**: 20230316

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RiceBran Technologies
- **CENTRAL INDEX KEY:** 0001063537
- **STANDARD INDUSTRIAL CLASSIFICATION:** GRAIN MILL PRODUCTS [2040]
- **IRS NUMBER:** 870673375
- **STATE OF INCORPORATION:** CA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36245
- **FILM NUMBER:** 23738838

**BUSINESS ADDRESS:**
- **STREET 1:** 25420 KUYKENDAHL ROAD, SUITE B300
- **CITY:** TOMBALL
- **STATE:** TX
- **ZIP:** 77375
- **BUSINESS PHONE:** 2816752421

**MAIL ADDRESS:**
- **STREET 1:** 25420 KUYKENDAHL ROAD, SUITE B300
- **CITY:** TOMBALL
- **STATE:** TX
- **ZIP:** 77375

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NUTRACEA
- **DATE OF NAME CHANGE:** 20030930

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NUTRASTAR INC
- **DATE OF NAME CHANGE:** 20011221

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ALLIANCE CONSUMER INTERNATIONAL INC
- **DATE OF NAME CHANGE:** 20010418

ribt20230315_8k.htm

------

**UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, D.C. 20549**

------

**FORM **8-K**

------

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(D) OF THE**

 **SECURITIES EXCHANGE ACT OF 1934**

**Date of report (Date of earliest event reported): **March 16, 2023**

------

---

| |
|:---|
| **RICEBRAN TECHNOLOGIES** |
| (Exact Name of registrant as specified in its charter) |

---

------

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp; **California** |  |
|  | (State or other jurisdiction of incorporation) |  |
| **0-32565** |  | **87-0673375** |
| (Commission File Number) |  | (IRS Employer Identification No.) |
| **25420 Kuykendahl Rd., Suite B300**<br> **Tomball**, **TX** |  | **77375** |
| (Address of principal executive offices) |  | (Zip Code) |
| **(**281**) **675-2421** | **(**281**) **675-2421** | **(**281**) **675-2421** |
| Registrant's telephone number, including area code | Registrant's telephone number, including area code | Registrant's telephone number, including area code |
| **Not Applicable** | **Not Applicable** | **Not Applicable** |
| (Former name or former address, if changed since last report) | (Former name or former address, if changed since last report) | (Former name or former address, if changed since last report) |

---

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, no par value per share | RIBT | The NASDAQ Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02 Results of Operations and Financial Condition.**

On March 16, 2023, RiceBran Technologies issued a press release announcing certain financial results for the three and twelve months ended December 31, 2022. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.

The information furnished in this Current Report on Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits.** |
| **Exhibit**<br> **No.** | **Description** |
| 99.1 | [Press Release issued March 16, 2023.](ex_489377.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | RICEBRAN TECHNOLOGIES | RICEBRAN TECHNOLOGIES |
| Date: March 16, 2023 | By:  | /s/ Todd T. Mitchell |
|  | Name: | Todd T. Mitchell |
|  | Title: | Chief Financial Officer |
|  |  | (Duly Authorized Officer) |

---

## Exhibit 99.1

**Exhibit 99.1**

![image01.jpg](image01.jpg)

**RiceBran Technologies Reports Fourth Quarter 2022 Results**

**TOMBALL, Texas, March 16, 2023** – RiceBran Technologies (NASDAQ: RIBT) (the "Company"), a global leader in the development and manufacture of nutritional and functional ingredients derived from rice and other small and ancient grains for human food, nutraceutical, pet care and equine feed applications, today announced financial results for the fourth quarter ended December 31, 2022.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **<u>Summary Results ($000s)</u>** | **<u>4Q22</u>** | **<u>4Q21</u>** | **<u>% Chg.</u>** | **<u>Qual</u>** | **<u>FY22</u>** |  **<u>FY21</u>** | **<u>% Chg.</u>** | **<u>Qual</u>** |
| Revenue | $10616 | $8043 | 32% | Improved | $41617 | $31131 | 34% | Improved |
| Gross Profit (Loss) | $(87) | $(107) | (19%) | Improved | $(759) | $442 | NM | Declined |
| SG&A | $1525 | $1611 | (5%) | Improved | $6690 | $7087 | (6%) | Improved |
| Operating Loss | $(1612) | $(5634) | (71%) | Improved | $(7302) | $(10566) | (31%) | Improved |
| Net Loss | $(1679) | $(5404) | (69%) | Improved | $(7858) | $(8949) | (12%) | Improved |
| Adj. EBITDA Loss (non-GAAP)\* | $(654) | $(806) | (19%) | Improved | $(3766) | $(2927) | 29% | Declined |

---

\* *Reconciliation of GAAP to Non-GAAP measures follows.*

**Fourth Quarter and Full Year 2022 Financial Highlights**

RiceBran generated a 34% increase in revenue in 2022, driven by strong growth from both specialty milling businesses, and higher core-SRB sales. Gross losses for the year, compared to gross profits in 2021, were due to a decline in Value-add SRB derivatives sales and profit contribution which offset improvements in all other businesses. Operating and net losses declined for the year due to non-cash charges in 2021, excluding these benefits, adjusted EBITDA losses increased for the year due to lower gross profit contributions. Favorable trends in the fourth quarter were driven by significant operational improvements at Golden Ridge and efforts to reduce SG&A.

&nbsp;&nbsp;&nbsp;&nbsp;● **Revenue grew 34% in 2022 to nearly $42 million.** Total revenue was $10.6 million in the fourth quarter of 2022, a 32% increase from $8 million in the fourth quarter of 2021. Total revenue was $41.6 million in 2022, a 34% increase from $31.1 million in 2021. Growth for the quarter, and for the year, was led by MGI and Golden Ridge, and helped by growth in core-SRB sales, offset by a decline in Value-add SRB derivative sales.

&nbsp;&nbsp;&nbsp;&nbsp;● **Company returns to gross losses for the year.** Gross losses were $87,000 in the fourth quarter of 2022, versus gross losses of $107,000 a year ago. Gross losses were $759,000 for the full year 2022, a $1.2 million decline from gross profits of $442,000 in 2021. Losses for the quarter, and for the year, were driven by a decline in Value-add SRB derivative sales, offset by improved results from Golden Ridge and MGI.

&nbsp;&nbsp;&nbsp;&nbsp;● **SG&A fell to 14% of sales in 2022 from 20% in 2021.** SG&A in the fourth quarter declined 5% to $1.5 million from $1.6 million a year ago. Total SG&A for the year declined 6% to $6.7 million, from $7.1 million in 2021. Lower SG&A for the quarter, and for the year, was driven by reductions in director compensation and lower corporate overhead expenses, principally lower compensation expenses.

------

&nbsp;&nbsp;&nbsp;&nbsp;● **Operating and net losses widen due to gross losses.** Operating losses for the year fell 31% to $7.3 million from $10.6 million in 2021, while net losses declined 12% in 2022 to $7.9 million, or $1.42 per share, from $9 million, or $1.87 per share, in 2021. Net losses in 2021 included a gain of $1.8 million in the first quarter for the forgiveness of the SBA PPP loan, and a $3.9 million charge in the fourth quarter for goodwill impairment.

&nbsp;&nbsp;&nbsp;&nbsp;● **Adjusted EBITDA (non-GAAP\*) losses rise in 2022.** Adjusted EBITDA losses were $654,000 in the fourth quarter of 2022, a 19% decrease from losses of $806,000 in the fourth quarter of 2021. Adjusted EBITDA losses for 2022 were $3.8 million, a 29% increase from losses of $2.9 million in 2021. The improvement in the fourth quarter stemmed from a significant improvement in contribution from Golden Ridge, while the decline for the year reflected the decline in contribution from our Value-Add SRB derivatives business.

&nbsp;&nbsp;&nbsp;&nbsp;● **Company ends 2022 with $3.9 million in cash.** RiceBran ended 2022 with $3.9 million in total cash, down from $5.8 million at the end of 2021. The year-over-year decline in total cash was due to higher operating losses in 2022 than 2021. RiceBran raised $2.1 million in the fourth quarter of 2022, $1.3 million in net proceeds from the sale of common stock, and $0.9 million from refinancing Golden Ridge's term loan.

**Fourth Quarter and Full Year 2022 Operating Highlights**

RiceBran operations saw mixed results in 2022. The milling businesses generated strong growth and an improved profit contribution. The core-SRB business continued to deliver double digit revenue growth, but the SRB derivatives business continued to face market and operational challenges.

&nbsp;&nbsp;&nbsp;&nbsp;● **Golden Ridge turnaround realized in the fourth quarter.** After being a significant drag on RiceBran results since its acquisition, Golden Ridge delivered its first full-quarter positive contribution to adjusted EBITDA in the fourth quarter as the benefits of continued improvement in operations coalesced with strong sourcing and sales execution under the new operating agreement with Gander Foods.

&nbsp;&nbsp;&nbsp;&nbsp;● **MGI grew profit contribution and expanded operations.** MGI delivered robust sales growth and more than doubled its contribution to adjusted EBITDA in 2022. Strong execution from the local team supported continuation of these trends in the fourth quarter despite the disruption from capital improvements. This project increased capacity by 50% and broadened MGI's capabilities to provide a solid growth platform.

&nbsp;&nbsp;&nbsp;&nbsp;● **Core SRB business generated double digit growth.** RiceBran was able to accelerate growth in its core-SRB business through strong execution, although results fell short of expectations due to technical issues with new applications. The benefits of higher volumes and solid pricing trends were largely offset by higher input and operating costs resulting in little change in the business's contribution to adjusted EBITDA.

&nbsp;&nbsp;&nbsp;&nbsp;● **Setbacks in Value-add SRB derivatives weigh on overall results.** RiceBran's Value-add SRB derivatives business saw a significant decline in revenue and contribution to adjusted EBITDA in 2022 that offset gains elsewhere. Setbacks in this business were driven by raw material and processing issues which led to inadequate production and resulted in customer losses in the face of new competition.

In light of RiceBran's challenges in achieving its operating and financial targets in 2022, the Company is currently undergoing a strategic review of all the possible alternatives to generate improved returns to its shareholders.

------

**Conference Call Information**

RiceBran Technologies will host a conference call today, Thursday, March 16, at 4:30 p.m. EST to discuss the Company's financial results for the fourth quarter ended December 31, 2022.

The call information is as follows:

● Date: March 16, 2023

● Time: 4:30 p.m. Eastern Standard Time

● Toll Free Dial-in number for US/Canada: 888-506-0062

● Dial-In number for international callers: 973-528-0011

● Participant Access Code: 189245

● Webcast: https://www.ricebrantech.com/investors

Following the conclusion of the live call, a replay of the webcast will be available on the Investor Relations section of the Company's website for at least 90 days. A telephonic replay of the conference call will also be available from 7 p.m. EST on March 16, 2023, until 11:59 p.m. EST on March 30, 2023, by dialing 877-481-4010 (United States) or 919-882-2331 (international) and using the passcode 47775.

**About RiceBran Technologies**

RiceBran Technologies is a specialty ingredient company focused on the development, production, and marketing of products derived from traditional and ancient small grains. Notably, we are a global leader in the production and marketing of stabilized rice bran (SRB), and high value-added derivative products derived from SRB, as well as a processor of rice, rice co-products, and barley and oat products. We create and produce products utilizing proprietary processes to deliver improved nutrition, ease of use, and extended shelf-life, while addressing consumer demand for all natural, non-GMO and organic products. The target markets for our products include food and animal nutrition manufacturers and retailers, as well as specialty food, functional food and nutritional supplement manufacturers and retailers, both domestically and internationally. More information can be found in the Company's filings with the SEC and by visiting our website at http://www.ricebrantech.com.

**Forward-Looking Statements**

This release contains forward-looking statements, including, but not limited to, statements about RiceBran's expectations regarding its future financial results, sales growth, adjusted EBITDA (non-GAAP) improvements, and SG&A. These statements are made based upon current expectations that are subject to known and unknown risks and uncertainties, including the risks that operations are disrupted by the COVID-19 pandemic and timing of profitable operations. RiceBran Technologies does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in RiceBran Technologies' filings with the Securities and Exchange Commission, including its most recent periodic reports.

------

**Use of Non-GAAP Financial Information**

We utilize "adjusted EBITDA" "Net Cash" and "Net Debt" as supplemental measures in our ongoing analysis of short term and long-term cash requirement and liquidity needs. Management uses adjusted EBITDA as an indicator of our current financial performance. By eliminating the impact of all material non-cash charges as well as items that do not regularly occur, we believe that adjusted EBITDA provides a more accurate and informative indicator of our cash requirements. Adjusted EBITDA does not represent cash flows from operations as defined by generally accepted accounting principles ("GAAP"), is not a measure derived in accordance with GAAP and should not be considered as an alternative to net income (the most comparable GAAP financial measure to adjusted EBITDA).

The tables below contain a reconciliation of net loss (GAAP) and adjusted EBITDA (non-GAAP) for the three and nine months ended December 31, 2022 and December 31, 2021, and for Net Cash (non-GAAP) and Net Debt (non-GAAP) for the periods ended December 31, 2022 and December 31, 2021. We do not provide a reconciliation of forward-looking net loss (GAAP) to adjusted EBITDA (non-GAAP). Due to the nature of certain reconciling items, it is not possible to predict with any reliability what future outcomes may be with regard to the expense or income that may ultimately be recognized in future periods. Any forward-looking adjusted EBITDA information that we may provide from time to time consistently excludes the same items from projected net loss that are excluded from actual net loss in the table below.

**Investor Contact** 

Rob Fink

FNK IR

<u>ribt@fnkir.com</u>

646.809.4048 ------

---

| |
|:---|
| **RiceBran Technologies** |
| **Consolidated Income Statement (GAAP)** |
| (in $000, except per share amounts) |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **3 Months Ended (Unaudited)** | **3 Months Ended (Unaudited)** | **3 Months Ended (Unaudited)** |  | **12 Months Ended** | **12 Months Ended** | **12 Months Ended** |  |
|  | **12/31/22** | **12/31/21** | **% Chg.** |  | **12/31/22** | **12/31/21** | **% Chg.** |  |
| **Revenue** | $**10616** | $**8043** | **32** | **%** | $**41617** | $**31131** | **34** | **%** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cost of Goods Sold | (10703) | (8150) | 31 | % | **(42376)** | $**(30689)** | 38 | % |
| **Gross Profit (Loss)** | **(87)** | **(107)** | (19) | %) | **(759)** | **442** | **NM** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Gross Margin* | *(1 %)* | *(1 %)* | | | *(2 %)* | *1 %* | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Selling, General & Admin. | (1525) | (1611) | (5) | %) | (6690) | (7087) | (6) | %) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impairment of goodwill |  | (3915) | NM |  |  | (3915) | NM |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss (Gain) on PP&E |  | (1) | NM |  | 147 | (6) | NM |  |
| **Operating Loss** | $**(1612)** | $**(5634)** | **(71** | **%)** | $**(7302)** | $**(10566)** | **(31** | **%)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest Expense | (163) | (110) | 48 | % | (550) | (462) | 19 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gain on Extinguishment of PPP loan |  |  |  |  |  | 1792 | NM |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in FV of Derivative Warrant Liability | 165 | 389 | (58) | %) | 189 | 389 | (51) | %) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Expense | (70) | (29) | 141 | % | (176) | (81) | 117 | % |
| Loss Before Income Taxes | (1680) | (5384) | (69) | %) | (7839) | (8928) | (12) | %) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income Taxes | 1 | (20) | NM |  | (19) | (21) | NM |  |
| **Net Loss** | $**(1679)** | $**(5404)** | **(69** | **%)** | $**(7858)** | $**(8949)** | **(12** | **%)** |
| **Basic & Diluted Loss per Share:** | $**(0.28)** | $**(1.04)** | **(73** | **%)** | $**(1.42)** | $**(1.87)** | **(24** | **%)** |
| Weighted Avg. Shares Outstanding (Basic & Diluted): | 6039 | 5193 | 16 | % | 5515 | 4774 | 16 | % |

---

------

---

| |
|:---|
| **RiceBran Technologies** |
| **Consolidated Balance Sheets** |
| (in $000) |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Period Ending** | **Period Ending** | **Period Ending** |
|  | **12/31/22** | **12/31/21** | **% Chg.** |
| **Assets** |  |  |  |
| Cash and Cash Equivalents | $3941 | $5825 | (32%) |
| Accounts Receivable, net | 3703 | 4136 | (10%) |
| Inventories | 2378 | 2444 | (3%) |
| Other Current Assets | 1046 | 810 | 29% |
| **Total Current Assets** | $**11068** | $**13215** | **(16** **%)** |
| PP&E, Net | 14207 | 15444 | (8%) |
| Operating Lease right-of-use assets | 1778 | 2127 | (16%) |
| Intangibles | 380 | 527 | (28%) |
| **Total Assets** | $**27433** | $**31313** | **(12** **%)** |
| **Liabilities and Shareholders' Equity** |  |  |  |
| Accounts Payable | $1232 | $826 | 49% |
| Commodities Payable | 1546 | 1702 | (9%) |
| Accruals | 1820 | 1470 | 24% |
| Leases, Current | 516 | 468 | 10% |
| Debt, Current | 6163 | 4690 | 31% |
| **Total Current Liabilities** | $**11277** | $**9156** | **23%** |
| Leases, Not Current | 1882 | 2048 | (8%) |
| Debt, Not Current | 1296 | 1356 | (4%) |
| Derivative Warrant Liability | 69 | 258 | (73%) |
| **Total Liabilities** | $**14524** | $**12818** | **13%** |
| Preferred Stock | 75 | 75 |  |
| Common Stock | 328551 | 326279 | 1% |
| Accumulated Deficit | (315717) | (307859) | 3% |
| **Total Shareholders**' **Equity** | $**12909** | $**18495** | **(30** **%)** |
| **Total Liabilities and Shareholders**' **Equity** | $**27433** | $**31313** | **(12** **%)** |

---

------

---

| |
|:---|
| **RiceBran Technologies** |
| **Consolidated Statement of Cash Flows**  |
| (in $000) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **3 Months Ended (Unaudited)** | **3 Months Ended (Unaudited)** | **3 Months Ended (Unaudited)** | **12 Months Ended** | **12 Months Ended** | **12 Months Ended** |
|  | **12/31/22** | **12/31/21** | **% Chg.** | **12/31/22** | **12/31/21** | **% Chg.** |
| **Cash Flow from Operations** |  |  |  |  |  |  |
| Net Loss | $(1679) | $(5404) | (69%) | $(7858) | $(8949) | (12%) |
| Adjs. to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation | 528 | 576 | (8%) | 2103 | 2397 | (12%) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization | 31 | 45 | (31%) | 147 | 195 | (25%) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Share-Based Compensation | 399 | 292 | 37% | 1286 | 1132 | 14% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impairment of goodwill |  | 3915 | NM |  | 3915 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss (Gain) on Involuntary Conversion of PP&E |  | 1 | NM | (147) | 6 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gain on Extinguishment of PPP Debt |  |  |  |  | (1792) | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in FV of Derivative Warrant Liability | (165) | (389) | (58%) | (189) | (389) | (51%) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Provision for bad debts | (41) | 2 | NM | 64 | 15 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accretion of Interest | 24 | 83 | (71%) | 24 | 83 | (71%) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other | (34) | (54) | (37%) | (33) |  | NM |
| Changes in operating assets and liabilities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts Receivable | 1333 | (1314) | NM | 369 | (1332) | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventories | 309 | (271) | NM | 66 | (566) | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts Payable | (470) | (314) | 50% | 624 | 280 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commodities Payable | (414) | 257 | NM | (156) | 876 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other | 102 | 362 | (72%) | (236) | (69) | NM |
| **Net Cash Flow from Operations** | $**(77)** | $**(2213)** | **(97** **%)** | $**(3936)** | $**(4198)** | **(6** **%)** |
| **Cash Flow from Investing** |  |  |  |  |  |  |
| Purchases of PP&E | (152) | (253) | (40%) | (563) | (1440) | (61%) |
| Proceeds from Insurance on Involuntary Conversion |  | 1 | NM | 109 | 639 | (83%) |
| Proceeds from Sale of Property |  | 3 | NM |  | 3 | NM |
| **Net Cash Flow from Investing** | $**(152)** | $**(249)** | **NM** | $**(454)** | $**(798)** | **(43** **%)** |
| **Cash Flow from Financing** |  |  |  |  |  |  |
| Proceeds from Warrants Exercised |  |  |  |  | 171 |  |
| Proceeds from issuances of common stock and warrants | 1256 | (8) | NM | 1256 | 3364 | NM |
| Net Change in Debt | (1460) | 2107 | NM | 1250 | 2023 | (38%) |
| **Net Cash Flow from Financing** | $**(204)** | $**2099** | **NM** | $**2506** | $**5558** | **(55** **%)** |
| **Net Change in Cash** | $**(433)** | $**(363)** | **19%** | $**(1884)** | $**562** | **NM** |
| BOP Cash Balance | $4374 | $6188 |  | $5825 | $5263 |  |
| Net Change in Cash | (433) | (363) |  | (1884) | 562 |  |
| **EOP Cash Balance** | $**3941** | $**5825** |  | $**3941** | $**5825** |  |

---

------

---

| |
|:---|
| **RiceBran Technologies** |
| **EBITDA and Adjusted EBITDA Reconciliation (Unaudited) (Non-GAAP)** |
| (in $000) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **3 Months Ended** | **3 Months Ended** | **3 Months Ended** | **12 Months Ended** | **12 Months Ended** | **12 Months Ended** |
|  | **12/31/22** | **12/31/21** | **% Chg.** | **12/31/22** | **12/31/21** | **% Chg.** |
| Net Loss | $(1679) | $(5404) | (69%) | $(7858) | $(8949) | (12%) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest Expense | 163 | 110 | 48% | 550 | 462 | 19% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income Taxes | (1) | 20 | NM | 19 | 21 | (10%) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation and Amortization | 559 | 621 | (10%) | 2250 | 2592 | (13%) |
| **EBITDA** | $**(958)** | $**(4653)** | **(79** **%)** | $**(5039)** | $**(5874)** | **(14** **%)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gain on extinguishment of PPP loan |  |  |  |  | (1792) | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in FV of Derivative Warrant Liability | (165) | (389) | NM | (189) | (389) | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impairment of goodwill |  | 3915 | NM |  | 3915 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Expense | 70 | 29 | 141% | 176 | 81 | 117% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Share-Based Compensation | 399 | 292 | 37% | 1286 | 1132 | 14% |
| **Adjusted EBITDA** | $**(654)** | $**(806)** | **(19** **%)** | $**(3766)** | $**(2927)** | **29%** |

---

---

| |
|:---|
| **RiceBran Technologies** |
| **Net Cash and Net Debt Reconciliation (Unaudited) (Non-GAAP)** |
| (in $000) |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Period Ending** | **Period Ending** | **Period Ending** |
|  | **12/31/22** | **12/31/21** | **% Chg.** |
| Cash and Cash Equivalents | $3941 | $5825 | (32%) |
| Less: Total Debt, Current and Non-current | 7459 | 6046 | 23% |
| **Net Cash (Debt)** | $**(3518)** | $**(221)** | NM |

---